Neurotherapeutics

, Volume 14, Issue 3, pp 554–563

Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress

  • Jessica L. Maples-Keller
  • Carly Yasinski
  • Nicole Manjin
  • Barbara Olasov Rothbaum
Review

Abstract

Virtual reality (VR) refers to an advanced technological communication interface in which the user is actively participating in a computer-generated 3-dimensional virtual world that includes computer sensory input devices used to simulate real-world interactive experiences. VR has been used within psychiatric treatment for anxiety disorders, particularly specific phobias and post-traumatic stress disorder, given several advantages that VR provides for use within treatment for these disorders. Exposure therapy for anxiety disorder is grounded in fear-conditioning models, in which extinction learning involves the process through which conditioned fear responses decrease or are inhibited. The present review will provide an overview of extinction training and anxiety disorder treatment, advantages for using VR within extinction training, a review of the literature regarding the effectiveness of VR within exposure therapy for specific phobias and post-traumatic stress disorder, and limitations and future directions of the extant empirical literature.

Keywords

Extinction training exposure therapy technology specific phobias PTSD psychiatric treatment 

Supplementary material

13311_2017_534_MOESM1_ESM.pdf (1.2 mb)
ESM 1(PDF 1224 kb)

References

  1. 1.
    Riva G. Virtual reality in psychotherapy: review. CyberPsychol Behav 2005;8:220-230.CrossRefPubMedGoogle Scholar
  2. 2.
    Rizzo A, Buckwalter J, Neumann U. Virtual reality and cognitive rehabilitation: a brief review of the future. J Head Trauma Rehabil 1997;12:1-15.CrossRefGoogle Scholar
  3. 3.
    Rothbaum BO. Using virtual reality to help our patients in the real world. Depress Anxiety 2009;26:209-211.CrossRefPubMedGoogle Scholar
  4. 4.
    Anderson P, Rothbaum BO, Hodges L. Virtual reality: using the virtual world to improve quality of life in the real world. Bull Menninger Clin 2001;65:78-91.CrossRefPubMedGoogle Scholar
  5. 5.
    Rothbaum BO, Hodges LF. The use of virtual reality exposure in the treatment of anxiety disorders. Behav Modif 1999;23:507-525.CrossRefPubMedGoogle Scholar
  6. 6.
    Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013;382:1575-1586.CrossRefPubMedGoogle Scholar
  7. 7.
    Pavlov IP. Conditioned reflexes. An Investigation of the physiological activity of the cerebral cortex 1927. London: Oxford Univ. Press.Google Scholar
  8. 8.
    Myers KM, Davis M. Mechanisms of fear extinction. Mol Psychiatry 2007;12:120-150.CrossRefPubMedGoogle Scholar
  9. 9.
    Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialog Clin Neurosci 2015;17:337-346.Google Scholar
  10. 10.
    Foa EB, Kozak MJ. Emotional processing of fear: exposure to corrective information. Psychol Bull 1986;99:20-35.CrossRefPubMedGoogle Scholar
  11. 11.
    Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M. Virtual reality graded exposure in the treatment of acrophobia: a case report. Behav Ther 1995;26:547-554.CrossRefGoogle Scholar
  12. 12.
    Dinh HQ, Walker N, Hodges LF, Song C, Kobayashi A. Evaluating the importance of multi-sensory input on memory and the sense of presence in virtual environments. In: Proceedings of the Virtual Reality Annual International Symposium 1999;222-228.Google Scholar
  13. 13.
    American Psychiatric Association. DSM 5. Washington, DC: American Psychiatric Association; 2014.Google Scholar
  14. 14.
    Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatric Res 2012;21:169-184.CrossRefGoogle Scholar
  15. 15.
    Wolitzky-Taylor KB, Horowitz JD, Powers MB, Telch MJ. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev 2008;28:1021-1037.CrossRefPubMedGoogle Scholar
  16. 16.
    Choy Y, Fyer AJ, Lipsitz JD. Treatment of specific phobia in adults. Clin Psychol Rev 2007;27:266-286.CrossRefPubMedGoogle Scholar
  17. 17.
    Garcia-Palacios A, Botella C, Hoffman H, Fabregat S. Comparing acceptance and refusal rates of virtual reality exposure vs. in vivo exposure by patients with specific phobias. Cyberpsychol Behav 2007;10:722-724.CrossRefPubMedGoogle Scholar
  18. 18.
    Krijn M, Emmelkamp PM, Ólafsson RP, et al. Fear of flying treatment methods: virtual reality exposure vs. cognitive behavioral therapy. Aviat Space Environ Med 2007;78:121-128.PubMedGoogle Scholar
  19. 19.
    Maltby N, Kirsch I, Mayers M, Allen GJ. Virtual reality exposure therapy for the treatment of fear of flying: a controlled investigation. J Consult Clin Psychol 2002;70:1112-1118.CrossRefPubMedGoogle Scholar
  20. 20.
    Mühlberger A, Herrmann MJ, Wiedemann G, Ellgring H, Pauli P. Repeated exposure of flight phobics to flights in virtual reality. Behav Res Ther 2001;39:1033-1050.CrossRefPubMedGoogle Scholar
  21. 21.
    Mühlberger A, Wiedemann G, Pauli P. Efficacy of a one-session virtual reality exposure treatment for fear of flying. Psychother Res 2003;13:323-336.CrossRefPubMedGoogle Scholar
  22. 22.
    Rothbaum BO, Anderson P, Zimand E, Hodges L, Lang D, Wilson J. Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying. Behav Ther 2006;37:80-90.CrossRefPubMedGoogle Scholar
  23. 23.
    Rothbaum BO, Hodges L, Smith S, Lee JH, Price L. A controlled study of virtual reality exposure therapy for the fear of flying. J Consult Clin Psychol 2000;68:1020-1026.CrossRefPubMedGoogle Scholar
  24. 24.
    Rus-Calafell M, Gutiérrez-Maldonado J, Botella C, Baños RM. Virtual reality exposure and imaginal exposure in the treatment of fear of flying: a pilot study. Behav Modification 2013;37:568-590.CrossRefGoogle Scholar
  25. 25.
    Tortella-Feliu M, Botella C, Llabrés J, et al. Virtual reality versus computer-aided exposure treatments for fear of flying. Behav Modif 2011;35:3-30.CrossRefPubMedGoogle Scholar
  26. 26.
    Triscari MT, Faraci P, Catalisano D, D’Angelo V, Urso V. Effectiveness of cognitive behavioral therapy integrated with systematic desensitization, cognitive behavioral therapy combined with eye movement desensitization and reprocessing therapy, and cognitive behavioral therapy combined with virtual reality exposure therapy methods in the treatment of flight anxiety: a randomized trial. Neuropsychiatric Dis Treat 2015;11:2591-2598.Google Scholar
  27. 27.
    Ferrand M, Ruffault A, Tytelman X, Flahault C, Négovanska V. A cognitive and virtual reality treatment program for the fear of flying. Aerosp Med Hum Perform 2015;86:723-727.CrossRefPubMedGoogle Scholar
  28. 28.
    Kahan M, Tanzer J, Darvin D, Borer F. Virtual reality-assisted cognitive-behavioral treatment for fear of flying: acute treatment and follow-up. Cyberpsychol Behav 2000;3:387-392.CrossRefGoogle Scholar
  29. 29.
    Price M, Anderson P. The role of presence in virtual reality exposure therapy. J Anxiety Disord 2007;21:742-751.CrossRefPubMedGoogle Scholar
  30. 30.
    Znaidi F, Viaud-Delmon I, Jouvent R. Generic virtual reality treatment applied to space-related phobias. Annu Rev CyberTher Telemed 2006;4:175-179.Google Scholar
  31. 31.
    Meyerbröker K, Powers MB, Van Stegeren A, Emmelkamp PM. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychother Psychosom 2011;81:29-37.CrossRefGoogle Scholar
  32. 32.
    Mühlberger A, Weik A, Pauli P, Wiedemann G. One-session virtual reality exposure treatment for fear of flying: 1-year follow-up and graduation flight accompaniment effects. Psychother Res 2006;16:26-40.CrossRefGoogle Scholar
  33. 33.
    Mühlberger A, Wiedemann G, Pauli P. Subjective and physiologic reactions of flight phobics during VR exposure and treatment outcome: what adds motion simulation? Annu Rev CyberTher Telemed 2005;3:185-192.Google Scholar
  34. 34.
    Wiederhold BK, Jang DP, Gevirtz RG, Kim SI, Kim IY, Wiederhold MD. The treatment of fear of flying: a controlled study of imaginal and virtual reality graded exposure therapy. IEEE Trans Inf Technol Biomed 2002;6:218-223.CrossRefPubMedGoogle Scholar
  35. 35.
    Rothbaum BO, Hodges L, Anderson PL, Price L, Smith S. Twelve-month follow up of virtual reality and standard exposure therapies for the fear of flying. J Consult Clin Psychol 2002;70:428-432.CrossRefPubMedGoogle Scholar
  36. 36.
    Coelho CM, Silva CF, Santos JA, Tichon J, Wallis G. Contrasting the effectiveness and efficiency of virtual reality and real environments in the treatment of acrophobia. Psychnol J 2008;6:203-216.Google Scholar
  37. 37.
    Emmelkamp PM, Krijn M, Hulsbosch AM, De Vries S, Schuemie MJ, Van der Mast CA. Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia. Behav Res Ther 2002;40:509-516.CrossRefPubMedGoogle Scholar
  38. 38.
    Krijn M, Emmelkamp PM, Olafsson RP, Biemond R. Virtual reality exposure therapy of anxiety disorders: a review. Clin Psychol Rev 2004;24:259-281.CrossRefPubMedGoogle Scholar
  39. 39.
    Emmelkamp PM, Bruynzeel M, Drost L, van der Mast CA. Virtual reality treatment in acrophobia: a comparison with exposure in vivo. CyberPsychol Behav 2001;4:335-339.CrossRefPubMedGoogle Scholar
  40. 40.
    Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004;61:1136-1144.CrossRefPubMedGoogle Scholar
  41. 41.
    Tart CD, Handelsman PR, DeBoer LB, et al. Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res 2013;47:168-174.CrossRefPubMedGoogle Scholar
  42. 42.
    Smits JA, Rosenfield D, Otto MW, et al. D-Cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry 2013;73:1054-1058.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Côté S, Bouchard S. Documenting the efficacy of virtual reality exposure with psychophysiological and information processing measures. Appl Psychophysiol Biofeedback 2005;30:217-232.CrossRefPubMedGoogle Scholar
  44. 44.
    Bouchard S, Côté S, St-Jacques J, Robillard G, Renaud P. Effectiveness of virtual reality exposure in the treatment of arachnophobia using 3D games. Technol Health Care 2006;14:19-27.PubMedGoogle Scholar
  45. 45.
    Garcia-Palacios A, Hoffman H, Carlin A, Furness TU, Botella C. Virtual reality in the treatment of spider phobia: a controlled study. Behav Res Ther 2002;40:983-993.CrossRefPubMedGoogle Scholar
  46. 46.
    Michaliszyn D, Marchand A, Bouchard S, Martel MO, Poirier-Bisson J. A randomized, controlled clinical trial of in virtuo and in vivo exposure for spider phobia. Cyberpsychol Behav Social Netw 2010;13:689-695.CrossRefGoogle Scholar
  47. 47.
    St-Jacques J, Bouchard S, Bélanger C. Is virtual reality effective to motivate and raise interest in phobic children toward therapy? A clinical trial study of in vivo with in virtuo versus in vivo only treatment exposure. J Clin Psychiatry. 2010;71:924-931.CrossRefPubMedGoogle Scholar
  48. 48.
    Shiban Y, Pauli P, Mühlberger A. Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther 2013;51:68-74.CrossRefPubMedGoogle Scholar
  49. 49.
    Shiban Y, Brütting J, Pauli P, Mühlberger A. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample? J Behav Ther Exp Psychiatry 2015;46:133-140.CrossRefPubMedGoogle Scholar
  50. 50.
    Shiban Y, Schelhorn I, Pauli P, Mühlberger A. Effect of combined multiple contexts and multiple stimuli exposure in spider phobia: a randomized clinical trial in virtual reality. Behav Res Ther 2015;71:45-53.CrossRefPubMedGoogle Scholar
  51. 51.
    Botella C, Baños RM, Guerrero B, García-Palacios A, Quero S, Raya MA. Using a flexible virtual environment for treating a storm phobia. Psychnol J 2006;4:129-44.Google Scholar
  52. 52.
    Wald J, Taylor S. Preliminary research on the efficacy of virtual reality exposure therapy to treat driving phobia. CyberPsychol Behav 2003;6:459-465.CrossRefPubMedGoogle Scholar
  53. 53.
    Maskey M, Lowry J, Rodgers J, McConachie H, Parr JR. Reducing specific phobia/fear in young people with autism spectrum disorders (ASDs) through a virtual reality environment intervention. PLOS ONE 2014;9:1-12.CrossRefGoogle Scholar
  54. 54.
    Shiban Y, Peperkorn H, Alpers GW, Pauli P, Mühlberger A. Influence of perceptual cues and conceptual information on the activation and reduction of claustrophobic fear. J Behav Ther Exp Psychiatry 2016;51:19-26.CrossRefPubMedGoogle Scholar
  55. 55.
    Morina N, Ijntema H, Meyerbröker K, Emmelkamp PM. Can virtual reality exposure therapy gains be generalized to real-life? A meta-analysis of studies applying behavioral assessments. Behav Res Ther 2015;74:18-24.CrossRefPubMedGoogle Scholar
  56. 56.
    Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, Foa EB. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev 2010;30:635-641.CrossRefPubMedGoogle Scholar
  57. 57.
    Goncalves R, Pedrozo AL, Coutinho ES, Figueira I, Ventura P. Efficacy of virtual reality exposure therapy in the treatment of PTSD: a systematic review. PLOS ONE 2012;7:1-7 e48469.Google Scholar
  58. 58.
    DiMauro J. Exposure therapy for posttraumatic stress disorder: a meta-analysis. Mil Psychol 2014;26:120-130.CrossRefGoogle Scholar
  59. 59.
    Botella C, Serrano B, Baños RM, Garcia-Palacios A. Virtual reality exposure-based therapy for the treatment of post-traumatic stress disorder: a review of its efficacy, the adequacy of the treatment protocol, and its acceptability. Neuropsychiatr Dis Treat 2015;11:2533-2545.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Reger GM, Durham TL, Tarantino KA, Luxton DD, Holloway KM, Lee JA. Deployed soldiers’ reactions to exposure and medication treatments for PTSD. Psychol Trauma. 2013;5:309-316.CrossRefGoogle Scholar
  61. 61.
    Rothbaum BO, Hodges L, Alarcon R, et al. Virtual reality exposure therapy for PTSD Vietnam veterans: a case study. J Trauma Stress 1999;12:263-271.CrossRefPubMedGoogle Scholar
  62. 62.
    Difede J, Hoffman HG. Virtual reality exposure therapy for World Trade Center post-traumatic stress disorder: a case report. Cyberpsychol Behav 2002;5:529-535.CrossRefPubMedGoogle Scholar
  63. 63.
    Freedman SA, Hoffman HG, Garcia-Palacios A, Weiss PL, Avitzour S, Josman N. Prolonged exposure and virtual reality–enhanced imaginal exposure for PTSD following a terrorist bulldozer attack: a case study. Cyberpsychol Behav Social Netw 2010;13:95-101.CrossRefGoogle Scholar
  64. 64.
    Gerardi M, Rothbaum BO, Ressler KJ, Heekin M, Rizzo A. Virtual reality exposure therapy using a virtual Iraq: case report. J Trauma Stress 2008;21:209-213.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Tworus R, Szymanska S, Ilnicki S. A soldier suffering from PTSD, treated by controlled stress exposition using virtual reality and behavioral training. Cyberpsychol Behav Social Netw 2010;13:103-107.CrossRefGoogle Scholar
  66. 66.
    Beck JG, Palyo SA, Winer EH, Schwagler BE, Ang EJ. Virtual reality exposure therapy for PTSD symptoms after a road accident: an uncontrolled case series. Behav Ther 2007;38:39-48.CrossRefPubMedGoogle Scholar
  67. 67.
    Wood DP, Murphy JA, Center KB, et al. Combat related post traumatic stress disorder: a multiple case report using virtual reality graded exposure therapy with physiological monitoring. Stud Health Technol Inform 2008;132:556-561.PubMedGoogle Scholar
  68. 68.
    McLay RN, McBrien C, Wiederhold MD, Wiederhold BK. Exposure therapy with and without virtual reality to treat PTSD while in the combat theater: a parallel case series. Cyberpsychol Behav Social Netw 2010;13:37-42.CrossRefGoogle Scholar
  69. 69.
    McLay RN, Ram V, Murphy J, et al. Effect of virtual reality PTSD treatment on mood and neurocognitive outcomes. Cyberpsychol Behav Social Netw 2014;17:439-446.CrossRefGoogle Scholar
  70. 70.
    Ready DJ, Pollack S, Rothbaum BO, Alarcon RD. Virtual reality exposure for veterans with posttraumatic stress disorder. J Aggress Maltreat Trauma 2006;12:199-220.CrossRefGoogle Scholar
  71. 71.
    Difede J, Cukor J, Jayasinghe N, et al. Virtual reality exposure therapy for the treatment of posttraumatic stress disorder following September 11, 2001. J Clin Psychiatry 2007;68:1639-1647.CrossRefPubMedGoogle Scholar
  72. 72.
    McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Social Netw 2011;14:223-229.CrossRefGoogle Scholar
  73. 73.
    Rizzo A, Difede J, Rothbaum BO, Reger GM, Spitalnick J, Cukor J, Mclay R. Development and early evaluation of the Virtual Iraq/Afghanistan exposure therapy system for combat-related PTSD. Ann N Y Acad Sci 2010;1208:114-25.CrossRefPubMedGoogle Scholar
  74. 74.
    Reger GM, Koenen-Woods P, Zetocha K, et al. J Consult Clin Psychol 2016;84:946-959.CrossRefPubMedGoogle Scholar
  75. 75.
    Difede J, Cukor J, Wyka K, et al. D-Cycloserine augmentation of exposure therapy for post traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology 2014;39:1052-1058.CrossRefPubMedGoogle Scholar
  76. 76.
    Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry 2014;171:640-648.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Maples-Keller JL, Price M, Rauch S, Gerardi M, Rothbaum BO. Investigating relationships between PTSD symptom clusters within virtual reality exposure therapy for OEF/OIF veterans. Behav Ther 2017;48:147-155.CrossRefPubMedGoogle Scholar
  78. 78.
    Norrholm SD, Jovanovic T, Gerardi M, et al. Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. Behav Res Ther 2016;82:28-37.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Webb AK, Vincent AL, Jin AB, Pollack MH. Physiological reactivity to nonideographic virtual reality stimuli in veterans with and without PTSD. Brain Behav 2015;5:1-9.CrossRefGoogle Scholar
  80. 80.
    Motraghi TE, Seim RW, Meyer EC, Morissette SB. Virtual reality exposure therapy for the treatment of posttraumatic stress disorder: a methodological review using CONSORT guidelines. J Clin Psychol 2014;70:197-208.CrossRefPubMedGoogle Scholar
  81. 81.
    Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-1060.CrossRefPubMedGoogle Scholar
  82. 82.
    Powers MB, Emmelkamp PM. Virtual reality exposure therapy for anxiety disorders: A meta-analysis. J Anxiety Disord 2008;22:561-569.CrossRefPubMedGoogle Scholar
  83. 83.
    Meyerbröker K, Emmelkamp PM. Virtual reality exposure therapy in anxiety disorders: a systematic review of process-and-outcome studies. Depress Anxiety 2010;27:933-944.CrossRefPubMedGoogle Scholar
  84. 84.
    Maples-Keller JL, Jovanovic T, Norrholm S, Price M, Odenat L, Rothbaum BO. Targeting memory reconsolidation to prevent the return of fear of flying. Depress Anxiety 2017 Apr 5.Google Scholar
  85. 85.
    Opriş D, Pintea S, García-Palacios A, Botella C, Szamosközi Ş, David D. Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis. Depress Anxiety 2012;29:85-93.CrossRefPubMedGoogle Scholar
  86. 86.
    Parsons TD, Rizzo A. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry 2008;39:250-261.CrossRefPubMedGoogle Scholar

Copyright information

© The American Society for Experimental NeuroTherapeutics, Inc. 2017

Authors and Affiliations

  • Jessica L. Maples-Keller
    • 1
  • Carly Yasinski
    • 1
  • Nicole Manjin
    • 1
  • Barbara Olasov Rothbaum
    • 1
  1. 1.Department of Psychiatry and Behavioral SciencesEmory University School of MedicineAtlantaUSA

Personalised recommendations